KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $39.8 billion.

  • Cvs Health's Receivables - Net rose 907.62% to $39.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $39.8 billion, marking a year-over-year increase of 907.62%. This contributed to the annual value of $39.8 billion for FY2025, which is 907.62% up from last year.
  • As of Q4 2025, Cvs Health's Receivables - Net stood at $39.8 billion, which was up 907.62% from $43.9 billion recorded in Q3 2025.
  • Over the past 5 years, Cvs Health's Receivables - Net peaked at $43.9 billion during Q3 2025, and registered a low of $2.3 billion during Q2 2023.
  • Its 5-year average for Receivables - Net is $27.8 billion, with a median of $29.7 billion in 2022.
  • Per our database at Business Quant, Cvs Health's Receivables - Net tumbled by 9156.91% in 2023 and then soared by 131049.65% in 2024.
  • Over the past 5 years, Cvs Health's Receivables - Net (Quarter) stood at $24.4 billion in 2021, then increased by 11.65% to $27.3 billion in 2022, then grew by 29.15% to $35.2 billion in 2023, then increased by 3.53% to $36.5 billion in 2024, then increased by 9.08% to $39.8 billion in 2025.
  • Its last three reported values are $39.8 billion in Q4 2025, $43.9 billion for Q3 2025, and $40.7 billion during Q2 2025.